Uzedy

[anonymous]

Does anyone think this drug will get launched? What will happen if it doesn't?

 

[anonymous]

Does anyone think this drug will get launched? What will happen if it doesn't?

Good question. If it does make it, it will be incredibly hard to sell with all the great competition out there. There is no medical need for Uzedy. If it doesn’t make it, they will have to do a huge reorganization with many being laid off. Austedo is a niche type drug, with a small market. Too many people trying to sell it now.

 

[anonymous]

Good question. If it does make it, it will be incredibly hard to sell with all the great competition out there. There is no medical need for Uzedy. If it doesn’t make it, they will have to do a huge reorganization with many being laid off. Austedo is a niche type drug, with a small market. Too many people trying to sell it now.

Ya, teva put its reps in a hard spot. Uzedy reps are leaving because they do not have a drug. NS reps are leaving because they feel ajovy is not selling and will be laid off soon. Austedo reps are leaving because it's crowded with NH now selling the drug and are worried about a reorg. I do not see austedo as a niche drug. It will eventually break a billion. Probably not this year, but next year. Sven and other executives at teva will do their best to slow sales, but austedo will break a billion eventually. At least they know people are leaving based on that call last week. They spent a lot of time talking about people leaving teva

 

[anonymous]

Ya, teva put its reps in a hard spot. Uzedy reps are leaving because they do not have a drug. NS reps are leaving because they feel ajovy is not selling and will be laid off soon. Austedo reps are leaving because it's crowded with NH now selling the drug and are worried about a reorg. I do not see austedo as a niche drug. It will eventually break a billion. Probably not this year, but next year. Sven and other executives at teva will do their best to slow sales, but austedo will break a billion eventually. At least they know people are leaving based on that call last week. They spent a lot of time talking about people leaving teva

You are spot on. Pharma companies have layoffs every 2-3yrs. Teva is under poor leadership. You can expect layoffs every 6 months.

 

[anonymous]

The difference with the Teva situation and that of other pharma companies is that attrition within the Uzedy and Ajovy folks will take care of itself. As folks leave there will be no backfilling of open territories. By the time Q-4 rolls around and the prospect of Austedo getting that much closer to a Billion $ drug, re-aligning of Psych and Neuro should be pretty simple. The Austedo brand will still need 400+ reps with all the call points and providers who have impact on TD and HD. Plus there is still a lot of un-tapped business out the in LTC and CMHC.

 

[anonymous]

The difference with the Teva situation and that of other pharma companies is that attrition within the Uzedy and Ajovy folks will take care of itself. As folks leave there will be no backfilling of open territories. By the time Q-4 rolls around and the prospect of Austedo getting that much closer to a Billion $ drug, re-aligning of Psych and Neuro should be pretty simple. The Austedo brand will still need 400+ reps with all the call points and providers who have impact on TD and HD. Plus there is still a lot of un-tapped business out the in LTC and CMHC.

Is that you sven? Or some uzedy rep drunk on the kool-aid? How many reps you think sell ingrezza? Austedo is heavily saturated with reps. Way more than ingrezza. Fact is the moment Shared Solutions was outsourced it has not been the same as it was under copaxone. We are 4-5 years to late to the LTC. Until austedo is once a day...LTCs will not care. Even with a strong d2d argument. All we are doing with 400+ reps selling austedo is pissing off offices/prescribers. As for you idiotic point about backfilling...ya, maybe a few spots, but they will cut uzedy reps if the drug is not approved. Based on NS with ajovy, I see another massive layoff there like last year. NeuroPsych is probably the safest. But, we will see attrition there. I think morale is so low and people are so burned out on poor sales leadership at the top, they are leaving like with what happened when teva reps went to Neurocrine a 5 months ago.

 

[anonymous]

Is that you sven? Or some uzedy rep drunk on the kool-aid? How many reps you think sell ingrezza? Austedo is heavily saturated with reps. Way more than ingrezza. Fact is the moment Shared Solutions was outsourced it has not been the same as it was under copaxone. We are 4-5 years to late to the LTC. Until austedo is once a day...LTCs will not care. Even with a strong d2d argument. All we are doing with 400+ reps selling austedo is pissing off offices/prescribers. As for you idiotic point about backfilling...ya, maybe a few spots, but they will cut uzedy reps if the drug is not approved. Based on NS with ajovy, I see another massive layoff there like last year. NeuroPsych is probably the safest. But, we will see attrition there. I think morale is so low and people are so burned out on poor sales leadership at the top, they are leaving like with what happened when teva reps went to Neurocrine a 5 months ago.

Fuck you’re dumb. Arrogant NP prick making a case for your job. Nobody is safer than anybody else. The number of reps on Austedo now is very close to Neurocrine across the 3 divisions. We are matched and the better product will grow.

I have sold Ajovy longer than you’ve been with Teva and can tell you every year it’s the same argument about layoffs due to poor sales. Teva backs it’s people as best they can. But stop shitting on people, Teva, and other divisions. If you or any other rep truly thinks you’re safe anywhere you’re fooling yourself. This is a business and not personal.

 

[anonymous]

Fuck you’re dumb. Arrogant NP prick making a case for your job. Nobody is safer than anybody else. The number of reps on Austedo now is very close to Neurocrine across the 3 divisions. We are matched and the better product will grow.

I have sold Ajovy longer than you’ve been with Teva and can tell you every year it’s the same argument about layoffs due to poor sales. Teva backs it’s people as best they can. But stop shitting on people, Teva, and other divisions. If you or any other rep truly thinks you’re safe anywhere you’re fooling yourself. This is a business and not personal.

Get a grip kid. You are so worked up you can't even read. The guy never said safe, he said safest. Which does not mean lay-off proof. Just least likely to be laid-off.

Also, teve will cut uzedy reps if uzedy is not approved. Uzedy is a drug by medicell. Look it up. Teva is not going to keep those reps if the drug is not approved. Come on man, teva is not going to do a company wide sales layoff/reorganization because they hired a sales force with no drug.

Lastly, neurocrine does not have 400+ reps selling ingrezza. Lol! They have a small ltc, a mix and designated sales force for ingrezza. Teva now does too for austedo. Plus another 130-160 uzedy reps selling austedo. I say 130-160 because they are leaving. Especially on the ltc side from what I hear.

 

[anonymous]

Used reps are not leaving. You're just wishing they were. They are a great group of 120 reps. They are here to take austedo to a billion.

 

[anonymous]

Used reps are not leaving. You're just wishing they were. They are a great group of 120 reps. They are here to take austedo to a billion.

Any Uzedy rep not looking for a way out is a fool. It is a very experienced sales force that came here for a launch. Now they are calling on targets who 1) Are already being called on, 2) Have had little/no access or Austedo interest in the past. Personally I am in final rounds of interviews and I am ready to bail. I did not come here to share a territory.

 

[anonymous]

Any Uzedy rep not looking for a way out is a fool. It is a very experienced sales force that came here for a launch. Now they are calling on targets who 1) Are already being called on, 2) Have had little/no access or Austedo interest in the past. Personally I am in final rounds of interviews and I am ready to bail. I did not come here to share a territory.

I have been here for 7ys. I'm on NP and looking for the door too

 

[anonymous]

At least the NH goals are reasonable…..
60% increase over weekly average! How is that even possible given this goofy overlap situation? How out of touch with reality is upper mgt? It feels to me like a set up to fail and easy substantiate the mass layoff.

 

[anonymous]

At least the NH goals are reasonable…..
60% increase over weekly average! How is that even possible given this goofy overlap situation? How out of touch with reality is upper mgt? It feels to me like a set up to fail and easy substantiate the mass layoff.

That is absolutely untrue. Where are you coming up with that? Q-2 goals were already set and didn't change with the additional Uzedy reps added to current territory footprints. We haven't seen anything on Q-3 goals yet and probably wont until the end of June.

 

[anonymous]

Did you not see I stated NH goals? NH stands for NeuroHealth, the division that was supposed to sell Uzedy. We are now selling Austedo and just received our Q2 goals. And they are ridiculous
Is that clear enough for you?

 

[anonymous]

Did you not see I stated NH goals? NH stands for NeuroHealth, the division that was supposed to sell Uzedy. We are now selling Austedo and just received our Q2 goals. And they are ridiculous
Is that clear enough for you?

Hey dumbass, those are the same goals we have here on the NP side. We have lived that type of % attainment increase quarter over quarter for the last 3 years now. Welcome to our world, now go out and sell some Austedo and get used to the fact that this ain't some "primary care sample drop-off " sell. If you have the tenured psych experience hype we've been hearing about, then this shouldn't be much of a challenge for you guys and hopefully we'll all get paid.

 

[anonymous]

Certainly there is no need for name calling, how rude!
I came from NP and yes the goals are also ridiculous but never as this high of an increase. I agree, let’s work together so we all get paid/stay employed.

 

[anonymous]

If the goals we just received for May and June are any indication to justify our time selling Austedo, then I think we just got the answer on how they will cut us loose. Paying for all this added headcount with the little bit of added sales revenue we may or may not generate, will not justify us being here and we'll be gone by August.

 

[anonymous]

It's obvious teva is going to have massive layoffs. The question will be how? Are letting go of everything uzedy or will it be an across the board reorg of the brand name sales divisions?

 

[anonymous]

It's obvious teva is going to have massive layoffs. The question will be how? Are letting go of everything uzedy or will it be an across the board reorg of the brand name sales divisions?

Lets just be realistic from a business standpoint, Ajovy isn't carrying its weight and never will with all the other migraine monoclonal antibodies on the market. The size of the NS sales teams (200+ Austedo/Ajovy) can't be justified. Now with the uncertainty of Uzedy ever coming to market (130+ NH reps), Austedo is the only true revenue producer at this point (190 NP reps).
In order to make the shareholders happy and trying to have at least 1 branded product look profitable, the only choice would be to have a massive re-org / layoff leaving about 250 reps carrying both Austedo and Ajovy in one bag. That means a reduction of about 300+ reps accross the 3 different brands.

 

[anonymous]

Lets just be realistic from a business standpoint, Ajovy isn't carrying its weight and never will with all the other migraine monoclonal antibodies on the market. The size of the NS sales teams (200+ Austedo/Ajovy) can't be justified. Now with the uncertainty of Uzedy ever coming to market (130+ NH reps), Austedo is the only true revenue producer at this point (190 NP reps).
In order to make the shareholders happy and trying to have at least 1 branded product look profitable, the only choice would be to have a massive re-org / layoff leaving about 250 reps carrying both Austedo and Ajovy in one bag. That means a reduction of about 300+ reps accross the 3 different brands.

Not saying I disagree with you, but using your own logic why not just dump the Uzedy reps? Keep NS doing what they are doing because Ajovy is still profitable its just not that profitable. Keep NS selling Austedo to Neurology and leave NP alone. I would think the smart decision is to release the NH division.